Search

Your search keyword '"Hiroyuki Kagechika"' showing total 333 results

Search Constraints

Start Over You searched for: Author "Hiroyuki Kagechika" Remove constraint Author: "Hiroyuki Kagechika" Language undetermined Remove constraint Language: undetermined
333 results on '"Hiroyuki Kagechika"'

Search Results

3. Data from Novel YAP1 Activator, Identified by Transcription-Based Functional Screen, Limits Multiple Myeloma Growth

5. A Novel Lithocholic Acid Derivative Upregulates Detoxification-Related Genes in Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids

6. A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery

8. Conformational Properties of Aromatic Amides Bearing Imidazole Ring and Acid-Induced

9. LRBA is essential for urinary concentration and body water homeostasis

10. Reconstituted depolarization-induced Ca2+ release platform for skeletal muscle disease mutation validation and drug discovery

11. Structural Development of Silicon‐Containing Retinoids: Structure–Activity Relationship Study of the Hydrophobic Pharmacophore of Retinobenzoic Acids Using Silyl Functionalities

14. Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release

15. Construction of Aromatic Multilayered Structures Based on the Conformational Properties of N,N’‐ Dimethylated Squaramide

16. Lithocholic Acid Derivatives as Potent Vitamin D Receptor Agonists

17. 6-Arylcoumarin as a Scaffold of Photofunctional Molecules with OFF–ON–OFF Type Regulation

18. Activation of β2‐adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells

19. Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2+ dynamics in primary skeletal myocytes

21. Development of Boron-Cluster-Based Progesterone Receptor Antagonists Bearing a Pentafluorosulfanyl (SF5) Group

22. Development of a water-soluble ryanodine receptor 1 inhibitor

24. Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy

25. Regulation of exosome secretion by cellular retinoic acid binding protein 1 contributes to systemic anti-inflammation

26. Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents

27. Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay

28. Androgen receptor modulators: a review of recent patents and reports (2012-2018)

29. Spontaneous chiral resolution of N,N′-diarylsquaramides: Formation of various types of one-handed helical networks during crystallization

30. A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine

31. Design, synthesis and antitumor activity of phthalazine-1,4-dione-based menaquinone analogs

32. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells

33. A novel RyR1 inhibitor prevents and rescues sudden death in a mouse model of malignant hyperthermia and heat stroke

34. Chemical Screening of Nuclear Receptor Modulators

35. Prostaglandin E

36. Development of Helical Aromatic Amide Foldamers with a Diphenylacetylene Backbone

41. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents

42. Development of Boron-Cluster-Based Progesterone Receptor Antagonists Bearing a Pentafluorosulfanyl (SF

43. Chemical compounds that suppress hypoxia-induced stress granule formation enhance cancer drug sensitivity of human cervical cancer HeLa cells

44. Self-assembly of Liquid-crystalline Squaramides

46. Novel YAP1 Activator, Identified by Transcription-Based Functional Screen, Limits Multiple Myeloma Growth

47. Crystal Engineering of N,N′-Diphenylurea Compounds Featuring Phenyl–Perfluorophenyl Interaction

48. Selective Reagent for Detection ofN-ε-Monomethylation of a Peptide Lysine Residue through SNAr Reaction

49. Development of nonsteroidal glucocorticoid receptor modulators based on N-benzyl-N-(4-phenoxyphenyl)benzenesulfonamide scaffold

50. CO 2 -expanded bio-based liquids as novel solvents for enantioselective biocatalysis

Catalog

Books, media, physical & digital resources